SCHEMBL105486

Kakonein is a lipid of Polyketides (PK) class. Kakonein is associated with abnormalities such as Fatty Liver, Chronic liver disease, Morphologically altered structure, Hypertensive disease and Cardiovascular Diseases. The involved functions are known as protein expression, Extravasation, Liver damage, mRNA Expression and cell activation. Kakonein often locates in Body tissue, Hepatic, Microvilli, Cytoplasm and Membrane. The associated genes with Kakonein are TJP1 gene, CD14 gene, iberiotoxin, AT-Rich Interactive Domain-Containing Protein 1A and NKS1 gene. The related lipids are dehydrosoyasaponin I and Steroids. The related experimental models are Knock-out.

Cross Reference

Introduction

To understand associated biological information of SCHEMBL105486, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with SCHEMBL105486?

SCHEMBL105486 is suspected in Chronic liver disease, Hypertensive disease, Cardiovascular Diseases, Myocardial Infarction, Cerebrovascular accident, Fatty Liver and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with SCHEMBL105486

MeSH term MeSH ID Detail
Amnesia D000647 12 associated lipids
Alzheimer Disease D000544 76 associated lipids
Adenocarcinoma D000230 166 associated lipids
Per page 10 20 50 | Total 43

PubChem Associated disorders and diseases

What pathways are associated with SCHEMBL105486

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with SCHEMBL105486?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with SCHEMBL105486?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with SCHEMBL105486?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with SCHEMBL105486?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with SCHEMBL105486?

Knock-out

Knock-out are used in the study 'MATE2 mediates vacuolar sequestration of flavonoid glycosides and glycoside malonates in Medicago truncatula.' (Zhao J et al., 2011).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with SCHEMBL105486

Download all related citations
Per page 10 20 50 100 | Total 919
Authors Title Published Journal PubMed Link
Hao LN et al. Toxicity of endogenous peroxynitrite and effects of puerarin on transplanted retinal pigment epithelial sheets in the subretinal space in mice. 2011 Int J Ophthalmol pmid:22553655
Hao LN et al. Effect of puerarin on retinal pigment epithelial cells apoptosis induced partly by peroxynitrite via Fas/FasL pathway. 2010 Int J Ophthalmol pmid:22553574
Li Y et al. Process parameters and morphology in puerarin, phospholipids and their complex microparticles generation by supercritical antisolvent precipitation. 2008 Int J Pharm pmid:18440736
Luo CF et al. Pharmacokinetics, tissue distribution and relative bioavailability of puerarin solid lipid nanoparticles following oral administration. 2011 Int J Pharm pmid:21392565
Li H et al. Biopharmaceutics classification of puerarin and comparison of perfusion approaches in rats. 2014 Int J Pharm pmid:24607203
Zhang Y et al. Characterization and evaluation of self-microemulsifying sustained-release pellet formulation of puerarin for oral delivery. 2012 Int J Pharm pmid:22366381
Wang Y et al. In vitro and in vivo anticancer activity of a novel puerarin nanosuspension against colon cancer, with high efficacy and low toxicity. 2013 Int J Pharm pmid:23089583
Pang Z et al. Gel formation of puerarin and mechanistic study during its cooling process. 2018 Int J Pharm pmid:30016673
Tu L et al. Effects of particle size on the pharmacokinetics of puerarin nanocrystals and microcrystals after oral administration to rat. 2013 Int J Pharm pmid:24120729
Qi H et al. Development of a poloxamer analogs/carbopol-based in situ gelling and mucoadhesive ophthalmic delivery system for puerarin. 2007 Int J Pharm pmid:17254725
Wang C et al. Protective effects of puerarin on acute lung and cerebrum injury induced by hypobaric hypoxia via the regulation of aquaporin (AQP) via NF-κB signaling pathway. 2016 Int. Immunopharmacol. pmid:27643664
Wang S et al. Puerarin protects against CCl4-induced liver fibrosis in mice: possible role of PARP-1 inhibition. 2016 Int. Immunopharmacol. pmid:27318789
Zhang F et al. Puerarin attenuates smoke inhalation injury by regulation of Th1/Th2 expression and inhibition of Th17 cells in rats. 2015 Int. Immunopharmacol. pmid:26218281
Wang Z et al. Protective effects of edaravone combined puerarin on inhalation lung injury induced by black gunpowder smog. 2015 Int. Immunopharmacol. pmid:25754765
Ullah MZ et al. Attenuation of inflammatory pain by puerarin in animal model of inflammation through inhibition of pro-inflammatory mediators. 2018 Int. Immunopharmacol. pmid:29909234
Li R et al. Puerarin, isolated from Kudzu root (Willd.), attenuates hepatocellular cytotoxicity and regulates the GSK-3β/NF-κB pathway for exerting the hepatoprotection against chronic alcohol-induced liver injury in rats. 2013 Int. Immunopharmacol. pmid:23751897
Liu Y et al. Lyophilized Powder of Catalpol and Puerarin Protected Cerebral Vessels from Ischemia by Its Anti-apoptosis on Endothelial Cells. 2017 Int. J. Biol. Sci. pmid:28367097
Xue Q et al. Lyophilized Powder of Catalpol and Puerarin Protects Neurovascular Unit from Stroke. 2016 Int. J. Biol. Sci. pmid:27019622
Liu Y et al. Amelioration of stroke-induced neurological deficiency by lyophilized powder of catapol and puerarin. 2014 Int. J. Biol. Sci. pmid:24719562
Chen F et al. Puerarin-induced immune hemolytic anemia. 2013 Int. J. Hematol. pmid:23661032
Yu D et al. Puerarin attenuates glucocorticoid-induced apoptosis of hFOB1.19 cells through the JNK- and Akt-mediated mitochondrial apoptotic pathways. 2015 Int. J. Mol. Med. pmid:26101183
Li W et al. Puerarin attenuates the daunorubicin-induced apoptosis of H9c2 cells by activating the PI3K/Akt signaling pathway via the inhibition of Ca2+ influx. 2017 Int. J. Mol. Med. pmid:29039532
Kang OH et al. Puerarin ameliorates hepatic steatosis by activating the PPARα and AMPK signaling pathways in hepatocytes. 2015 Int. J. Mol. Med. pmid:25605057
Zhou Y et al. Puerarin alleviates cognitive impairment and oxidative stress in APP/PS1 transgenic mice. 2014 Int. J. Neuropsychopharmacol. pmid:24345484
Zhang Y et al. Effects of puerarin on cholinergic enzymes in the brain of ovariectomized guinea pigs. 2013 Int. J. Neurosci. pmid:23668913
Kang H et al. Puerarin inhibits M2 polarization and metastasis of tumor-associated macrophages from NSCLC xenograft model via inactivating MEK/ERK 1/2 pathway. 2017 Int. J. Oncol. pmid:28101568
Zheng GM et al. Puerarin suppresses production of nitric oxide and inducible nitric oxide synthase in lipopolysaccharide-induced N9 microglial cells through regulating MAPK phosphorylation, O-GlcNAcylation and NF-κB translocation. 2012 Int. J. Oncol. pmid:22246431
Penetar DM et al. Pharmacokinetic profile of the isoflavone puerarin after acute and repeated administration of a novel kudzu extract to human volunteers. 2006 Jul-Aug J Altern Complement Med pmid:16884345
Keyler DE et al. Toxicity study of an antidipsotropic Chinese herbal mixture in rats: NPI-028. 2002 J Altern Complement Med pmid:12006125
Feng ZQ et al. The synthesis of puerarin derivatives and their protective effect on the myocardial ischemia and reperfusion injury. 2010 J Asian Nat Prod Res pmid:20924897
Wang PP et al. Puerarin stimulates osteoblasts differentiation and bone formation through estrogen receptor, p38 MAPK, and Wnt/β-catenin pathways. 2012 J Asian Nat Prod Res pmid:22917468
Zhang SY et al. The effect of puerarin on serum nitric oxide concentration and myocardial eNOS expression in rats with myocardial infarction. 2008 Mar-Apr J Asian Nat Prod Res pmid:18348063
Zhao R et al. NMR studies on puerarin and its interaction with beta-cyclodextrin. 2011 J Biol Phys pmid:22942483
Xu J et al. PVA hydrogels containing beta-cyclodextrin for enhanced loading and sustained release of ocular therapeutics. 2010 J Biomater Sci Polym Ed pmid:20507706
Xu J et al. Preparation and evaluation of a contact lens vehicle for puerarin delivery. 2010 J Biomater Sci Polym Ed pmid:20178685
Yang F et al. Osteoblast response to puerarin-loaded porous titanium surfaces: an in vitro study. 2012 J Biomed Mater Res A pmid:22374837
Yuan Y et al. Puerarin attenuates pressure overload-induced cardiac hypertrophy. 2014 J Cardiol pmid:23906530
He X et al. Purification of the isoflavonoid puerarin by adsorption chromatography on cross-linked 12% agarose. 2004 J Chromatogr A pmid:15584227
He X et al. Separation and purification of puerarin using beta-cyclodextrin-coupled agarose gel media. 2004 J Chromatogr A pmid:14753773
Lau CC et al. Rapid analysis of Radix puerariae by near-infrared spectroscopy. 2009 J Chromatogr A pmid:19185872
Chen SB et al. High-performance thin-layer chromatographic fingerprints of isoflavonoids for distinguishing between Radix Puerariae Lobate and Radix Puerariae Thomsonii. 2006 J Chromatogr A pmid:16714027
Delmonte P et al. Determination of isoflavones in dietary supplements containing soy, Red Clover and kudzu: extraction followed by basic or acid hydrolysis. 2006 J Chromatogr A pmid:16413562
Wang CY et al. Analysis of Puerariae radix and its medicinal preparations by capillary electrophoresis. 1998 J Chromatogr A pmid:9588018
Chen G et al. Determination of puerarin, daidzein and rutin in Pueraria lobata (Wild.) Ohwi by capillary electrophoresis with electrochemical detection. 2001 J Chromatogr A pmid:11510548
Yu Z et al. Determination of safflor yellow A, puerarin, ferulic acid, ginsenoside Rg1, and Rb1 in the Traditional Chinese Medicinal preparation Naodesheng injection by high-performance liquid chromatography. 2006 May-Jun J Chromatogr Sci pmid:16774713
Zeng X et al. Enhanced adsorption of puerarin onto a novel hydrophilic and polar modified post-crosslinked resin from aqueous solution. 2012 J Colloid Interface Sci pmid:22878002
Türer ÇC et al. The Local Effect of Puerarin on Critical-Sized Calvarial Defects. 2017 J Craniofac Surg pmid:27922959
Li W et al. Puerarin Improves Diabetic Aorta Injury by Inhibiting NADPH Oxidase-Derived Oxidative Stress in STZ-Induced Diabetic Rats. 2016 J Diabetes Res pmid:26881260
Severino P et al. Current State-of-Art and New Trends on Lipid Nanoparticles (SLN and NLC) for Oral Drug Delivery. 2012 J Drug Deliv pmid:22175030
Li L and Zhang CR Production of puerarin and isoflavones in cell suspension cultures of Pueraria lobata (Willd.): effects of medium supplementation with casein hydrolysate and coconut milk. 2006 J Environ Biol pmid:16850870